Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis.
about
Re-evaluating the treatment of acute optic neuritis.Regulatory T cells in multiple sclerosis and myasthenia gravis.Influence of short-term glucocorticoid therapy on regulatory T cells in vivo.Increased presence of FOXP3+ regulatory T cells in inflamed muscle of patients with active juvenile dermatomyositis compared to peripheral bloodIntracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells.In vitro effects of meloxicam on the number, Foxp3 expression, production of selected cytokines, and apoptosis of bovine CD25+CD4+ and CD25-CD4+ cellsTranscriptional regulation of Foxp3 gene: multiple signal pathways on the road.Immunologic aspects of multiple sclerosis.The role of regulatory T cells in neurodegenerative diseases.Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse.Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.Effects of glucocorticoid treatment on CD25⁻FOXP3⁺ population and cytokine-producing cells in rheumatoid arthritis.Modification of anti-tumor immunity by tolerogenic dendritic cells.Regulatory effects of dexamethasone on NK and T cell immunity.Pathogenic T cells persist after reversal of autoimmune disease by immunosuppression with regulatory T cells.Central inflammation versus peripheral regulation in multiple sclerosis.Regulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells.Regulatory T Cells in Systemic Sclerosis
P2860
Q30865447-BA4B6C82-D5CA-4651-BC19-5F9F511D8797Q33784969-B5F9A734-1D06-44C5-A835-FCED89698306Q34017908-ED46CC8B-BBE8-433D-81B2-FD50EBFCA49CQ34089662-2C6EDFF0-238B-4346-9251-75B805A077DBQ34132839-1CBE4011-2A93-4494-8C56-FB36650D73F6Q36420758-6E4D2A09-8AA4-407D-89E8-87CDCB0922FCQ36958891-80A6B531-63F2-4772-B73C-4AD6357CED71Q37408217-AB545D66-37E8-4872-80C7-92FC11DE2656Q37855723-E5E280A6-D22B-48E0-A642-4B28BAAF9AF9Q38035240-453EF6A6-046B-4755-83D3-F43B8B4313D8Q38867574-2B55346F-26E2-49DF-9668-F54CE44D6D9EQ39349492-2A39BF09-AA31-4424-980E-D7EE53F97EC4Q41463764-937EB78E-61C1-4BF0-BA5A-7B228F397597Q42593149-58C251E8-1EBD-46CE-B1AE-6AF64053943DQ47983201-AB6F0BCC-FDCE-4A50-8016-89C645BA34A3Q48180064-8C6380E9-9AF7-4583-8D24-0F3761563EDCQ48265824-D9A06A6E-2974-4413-8204-554BA1C7E131Q50913348-97E2D262-D88C-4E91-A03C-6A068FC8B78CQ53249924-6BB85FA2-F7D8-44EA-8E77-412A297B2B0EQ55222194-A1372624-02BB-442C-A91A-1C0C0C935CC3Q58122062-9AA41798-7EAC-4BD1-904A-2D8C1A62C48E
P2860
Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Glucocorticoids increase CD4CD ...... ients with multiple sclerosis.
@ast
Glucocorticoids increase CD4CD ...... ients with multiple sclerosis.
@en
type
label
Glucocorticoids increase CD4CD ...... ients with multiple sclerosis.
@ast
Glucocorticoids increase CD4CD ...... ients with multiple sclerosis.
@en
prefLabel
Glucocorticoids increase CD4CD ...... ients with multiple sclerosis.
@ast
Glucocorticoids increase CD4CD ...... ients with multiple sclerosis.
@en
P2093
P2860
P1476
Glucocorticoids increase CD4CD ...... tients with multiple sclerosis
@en
P2093
P2860
P304
P356
10.1111/J.1600-0404.2008.01090.X
P407
P577
2009-04-01T00:00:00Z